Abstract
Caffeine is the most consumed psychoactive substance in the world; in general, it is not associated to potentially harmful effects. Nevertheless, few studies were performed attempting to investigate the caffeine addiction. The present review was mainly aimed to answer the following question: is caffeine an abuse drug? To adress this point, the effects of caffeine in preclinical and clinical studies were summarized and critically analyzed taking account the abuse disorders described in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). We concluded that the diagnostic criteria evidenced on DSM-V to intoxication-continued use and abstinence are not well supported by clinical studies. The fact that diagnostic criteria is not widely supported by preclinical or clinical studies may be due specially to a controversy in its exactly mechanism of action: recent literature point to an indirect, rather than direct modulation of dopamine receptors, and auto-limitant consumption due to adverse sensations in high doses. On the other hand, it reports clear withdrawal-related symptoms. Thus, based on a classical action on reward system, caffeine only partially fits its mechanism of action as an abuse drug, especially because previous research does not report a clear effect of dopaminergic activity enhance on nucleus accumbens; despite this, there are reports concerning dopaminergic modulation by caffeine on the striatum. However, based on human and animal research, caffeine withdrawal evokes signals and symptoms, which are relevant enough to include this substance among the drugs of abuse.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Acquas E, Tanda G, Di CG (2002) Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(02)00290-7
Alóe F, de Azevedo AP, Hasan R (2005) Sleep-wake cycle mechanisms. Rev Bras Psiquiatr 27(Suppl 1):33–39
Altimari LR, Serpeloni E, Zucas SM, Okano H, Burini RC (2001) Cafeína: ergogênico nutricional no esporte Caffeine: nutritional ergogenic in Sports Origem e descrição. R Bras Ciêne Mov 9:57–64
American Psychiatric Association (2013) Diagnostic and statistical manual of mental, 5th edn. American Psychiatric Publishing
Ashihara H (2006) Metabolism of alkaloids in coffee plants. Braz J Plant Physiol 18:1–8. https://doi.org/10.1590/S1677-04202006000100001
Atanasov AT (2007) The linear allometric relationship between total metabolic energy per life span and body mass of mammals. Biosystems 90:224–233. https://doi.org/10.1016/j.biosystems.2006.08.006
Baker LK, Mao D, Chi H, Govind AP, Vallejo YF, Iacoviello M, Herrera S, Cortright JJ, Green WN, McGehee DS, Vezina P (2013) Intermittent nicotine exposure upregulates nAChRs in VTA dopamine neurons and sensitises locomotor responding to the drug. Eur J Neurosci 37:1004–1011. https://doi.org/10.1111/ejn.12114
Braga LC, Alves MP (2000) A cafeína como recurso ergogênico nos exercícios de endurance. Rev Bras Ciênc Mov 8:33–37
Brenelli ECS (2003) A extração de cafeína em bebidas estimulantes: uma nova abordagem para um experimento clássico em química orgânica. Quim Nova 26:136–138. https://doi.org/10.1590/S0100-40422003000100023
Budney AJ, Lee DC, Juliano LM (2015) Evaluating the validity of caffeine use disorder. Curr Psychiatry Rep 17:74. https://doi.org/10.1007/s11920-015-0611-z
Caldwell GW, Masucci JA, Yan Z, Hageman W (2004) Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Eur J Drug Metab Pharmacokinet 29:133–143
Cauli O, Pinna A, Valentini V, Morelli M (2003) Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. Neuropsychopharmacology 28:1752–1759. https://doi.org/10.1038/sj.npp.1300240
Chen X, Ghribi O, Geiger JD (2010) Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer’s and Parkinson’s diseases. J Alzheimers Dis 20:127–141. https://doi.org/10.3233/JAD-2010-1376
Conlay LA, Conant JA, deBros F, Wurtman R (1997) Caffeine alters plasma adenosine levels. Nature 389:136–136. https://doi.org/10.1038/38160
Daly JW, Fredholm BB (1998) Caffeine—an atypical drug of dependence. Drug Alcohol Depend 51:199–206
De Luca MA, Bassareo V, Bauer A, Di Chiara G (2007) Caffeine and accumbens shell dopamine. J Neurochem 103:157–163. https://doi.org/10.1111/j.1471-4159.2007.04754.x
De Manzano O, Cervenka S, Karabanov A, Farde L, Ullén F (2010) Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. PLoS One 5:e10670. https://doi.org/10.1371/journal.pone.0010670
Dews PB, O’Brien CP, Bergman J (2002) Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol 40:1257–1261
Elmenhorst D, Basheer R, McCarley RW, Bauer A (2009) Sleep deprivation increases a(1) adenosine receptor density in the rat brain. Brain Res 1258:53–58. https://doi.org/10.1016/j.brainres.2008.12.056
Evans SM, Griffiths RR (1992) Caffeine tolerance and choice in humans. Psychopharmacology 108:51–59
Evans SM, Griffiths RR (1999) Caffeine withdrawal: a parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 289:285–294
Fenu S, Morelli M (1998) Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors. Eur J Neurosci 10:1878–1884
Ferré S (2016) Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology 233:1963–1979. https://doi.org/10.1007/s00213-016-4212-2
Ferré S (2010) Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J Alzheimers Dis 20:S35–S49. https://doi.org/10.3233/JAD-2010-1400
Ferré S, Bonaventura J, Tomasi D, Navarro G, Moreno E, Cortés A, Lluís C, Casadó V, Volkow ND (2016) Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer. Neuropharmacology 104:154–160. https://doi.org/10.1016/J.NEUROPHARM.2015.05.028
Ferré S, Ciruela F, Woods AS, Lluis C, Franco R (2007) Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends Neurosci 30:440–446. https://doi.org/10.1016/j.tins.2007.07.001
Ferré S, Herrera-Marschitz M, Grabowska-Andén M, Ungerstedt U, Casas M, Andén N-E (1991a) Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. Eur J Pharmacol 192:25–30. https://doi.org/10.1016/0014-2999(91)90064-W
Ferré S, von Euler G, Johansson B, Fredholm BB, Fuxe K (1991b) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci U S A 88:7238–7241
Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51:83–133
Fuxe K, Ungerstedt U (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med Biol 52:48–54
Ginovart N, A a W, Hussey D, Houle S, Kapur S (2009) D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats. Neuropsychopharmacology 34:662–671. https://doi.org/10.1038/npp.2008.116
Gopalakrishnan M, Molinari EJ, Sullivan JP (1997) Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52:524–534
Griffiths R, Evans S, Heishman S, Preston K, Sannerud C, Wolf B, Woodson P (1990) Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 255
Griffiths RR, Brady JV, Bradford LD (1979) Predicting the abuse liability of drugs with animal drug self-administration procedures: psychomotor stimulants and hallucinogens. Adv Behav Pharmacol 2:163–208. https://doi.org/10.1016/B978-0-12-004702-4.50010-2
Griffiths RR, Woodson PP (1988a) Reinforcing effects of caffeine in humans. J Pharmacol Exp Ther 246:21–29. https://doi.org/10.1016/0091-3057(91)90448-B
Griffiths RR, Woodson PP (1988b) Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 94:437–451
Griffiths RR, Woodson PP (1988c) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol Biochem Behav 29:419–427. https://doi.org/10.1016/0091-3057(88)90180-3
Juliano LM, Evatt DP, Richards BD, Griffiths RR (2012) Characterization of individuals seeking treatment for caffeine dependence. Psychol Addict Behav 26:948–954. https://doi.org/10.1037/a0027246
Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176:1–29
Kaasinen V, Aalto S, Någren K, Rinne JO (2004) Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15:281–285. https://doi.org/10.1097/00001756-200402090-00014
Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Kolbitsch C, Mottaghy FM, Felber SR, Jaschke WR, Krause BJ (2010) Caffeine and cognition in functional magnetic resonance imaging. J Alzheimers Dis 20:S71–S84
Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Verius M, Haala I, Mottaghy FM, Rhomberg P, Golaszewski S, Gotwald T, Lorenz IH, Kolbitsch C, Felber S, Krause BJ (2008) Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 39:492–499. https://doi.org/10.1016/j.neuroimage.2007.08.037
Mandel HG (2002) Update on caffeine consumption, disposition and action. Food Chem Toxicol 40:1231–1234
Marin MT, Zancheta R, Paro AH, Possi APM, Cruz FC, Planeta CS (2011) Comparison of caffeine-induced locomotor activity between adolescent and adult rats. Eur J Pharmacol 660:363–367. https://doi.org/10.1016/j.ejphar.2011.03.052
Meredith SE, Juliano LM, Hughes JR, Griffiths RR (2013) Caffeine use disorder: a comprehensive review and research agenda. J Caffeine Res 3:114–130. https://doi.org/10.1089/jcr.2013.0016
Nehlig A (1999) Are we dependent upon coffee and caffeine? A review on human and animal data. Neurosci Biobehav Rev 23:563–576
Nehlig A, Boyet S (2000) Dose-response study of caffeine effects on cerebral functional activity with a specific focus on dependence. Brain Res 858:71–77. https://doi.org/10.1016/S0006-8993(99)02480-4
Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139–170
Paes-De-Carvalho R (2002) Adenosine as a signaling molecule in the retina: biochemical and developmental aspects. An Acad Bras Cienc 74:437–451. https://doi.org/10.1590/S0001-37652002000300007
Pardo Lozano R, Alvarez García Y, Barral Tafalla D, Farré Albaladejo M (2007) Caffeine: a nutrient, a drug or a drug of abuse. Adicciones 19:225–238
Park C-A, Kang C-K, Son Y-D, Choi E-J, Kim S-H, Oh S-T, Kim Y-B, Park C-W, Cho Z-H (2014) The effects of caffeine ingestion on cortical areas: functional imaging study. Magn Reson Imaging 32:366–371. https://doi.org/10.1016/j.mri.2013.12.018
Peng X, Gerzanich V, Anand R, Whiting PJ, Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523–530
Pollack AE, Dimitrov KD, Drake JD (2010) Prior treatment (priming) with caffeine sensitizes D2-dopamine-mediated contralateral rotational behavior in 6-hydroxydopamine-lesioned rats. Pharmacology 86:73–78. https://doi.org/10.1159/000315496
Quarta D, Ferré S, Solinas M, You ZB, Hockemeyer J, Popoli P, Goldberg SR (2004) Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem 88:1151–1158. https://doi.org/10.1046/j.1471-4159.2003.02245.x
Rhoads DE, Huggler AL, Rhoads LJ (2011) Acute and adaptive motor responses to caffeine in adolescent and adult rats. Pharmacol Biochem Behav 99:81–86. https://doi.org/10.1016/j.pbb.2011.04.001
Ribeiro JA, Sebastio AM (2010) Caffeine and adenosine. J Alzheimer’s Dis S3–15
Rogers PJ, Elliman NA, Richardson NJ (1995) Overnight caffeine abstinence and negative reinforcement of preference for caffeine-containing drinks. Psychopharmacology 120:457–462
Schuh KJ, Griffiths RR (1997) Caffeine reinforcement: the role of withdrawal. Psychopharmacology 130:320–326
Solinas M, Ferré S, You Z-B, Karcz-Kubicha M, Popoli P, Goldberg SR (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci 22:6321–6324
Stoner GR, Skirboll LR, Werkman S, Hommer DW (1988) Preferential effects of caffeine on limbic and cortical dopamine systems. Biol Psychiatry 23:761–768. https://doi.org/10.1016/0006-3223(88)90064-9
Strain E, Griffiths R (1995) Caffeine dependence: fact or fiction? J R Soc Med 88:437–440
Striley CLW, Griffiths RR, Cottler LB (2011) Evaluating dependence criteria for caffeine. J Caffeine Res 1:219–225. https://doi.org/10.1089/jcr.2011.0029
Stringer KA, Watson WA (1987) Caffeine withdrawal symptoms. Am J Emerg Med 5:469. https://doi.org/10.1016/0735-6757(87)90416-5
Trifilieff P, Rives M-L, Urizar E, Piskorowski R, Vishwasrao H, Castrillon J, Schmauss C, Slättman M, Gullberg M, Javitch J (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques 51:111–118. https://doi.org/10.2144/000113719
Vitiello MV, Woods SC (1977) Evidence for withdrawal from caffeine by rats. Pharmacol Biochem Behav 6:553–555. https://doi.org/10.1016/0091-3057(77)90116-2
Volkow ND, Wang G-J, Logan J, Alexoff D, Fowler JS, Thanos PK, Wong C, Casado V, Ferre S, Tomasi D (2015) Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Transl Psychiatry 5:e549. https://doi.org/10.1038/tp.2015.46
Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492. https://doi.org/10.1037/0033-295X.94.4.469
Acknowledgements
We are grateful to CNPQ, for providing financial support to this work CNPQ-FAPESP–465458/2014-9 and 2014/50891-1-INCT Translacional em Medicina (465458/2014-9).
Author information
Authors and Affiliations
Contributions
VSR and BLS conceived the general structure of the article and selection methods. LSR and MKFS performed literature search and paper selection. MKFS, BLS, and ECG wrote the manuscript. VG, BLS, and ECG revised the manuscript for submission and the responses to reviewers. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
dos Santos, M.K.F., Gavioli, E.C., Rosa, L.S. et al. Craving espresso: the dialetics in classifying caffeine as an abuse drug. Naunyn-Schmiedeberg's Arch Pharmacol 391, 1301–1318 (2018). https://doi.org/10.1007/s00210-018-1570-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-018-1570-9